INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 67 filers reported holding INHIBRX INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $563,418 | -37.0% | 30,704 | -10.8% | 0.00% | 0.0% |
| Q2 2023 | $893,985 | +35.1% | 34,437 | -1.8% | 0.00% | 0.0% |
| Q1 2023 | $661,733 | -19.5% | 35,068 | +5.1% | 0.00% | 0.0% |
| Q4 2022 | $822,089 | +44.5% | 33,364 | +5.3% | 0.00% | 0.0% |
| Q3 2022 | $569,000 | +57.6% | 31,678 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $361,000 | -20.8% | 31,765 | +55.1% | 0.00% | 0.0% |
| Q1 2022 | $456,000 | -54.9% | 20,480 | -11.6% | 0.00% | 0.0% |
| Q4 2021 | $1,011,000 | +33.0% | 23,158 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $760,000 | -28.2% | 22,823 | -40.7% | 0.00% | 0.0% |
| Q2 2021 | $1,059,000 | +328.7% | 38,485 | +213.1% | 0.00% | – |
| Q1 2021 | $247,000 | -39.0% | 12,292 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $405,000 | – | 12,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |